On March 7, 2024, analyst Mike Hickey from Benchmark reiterated his bullish outlook on Genius Sports (NYSE:GENI), maintaining a Buy rating and a $10 price target. This reaffirmation underscores his ongoing confidence in the company’s performance and potential for growth. The consensus among analysts also remains positive, with a mean consensus of Buy and an average target price of $9.136 USD. This collective sentiment reflects a strong belief in the future success of Genius Sports.
GENI Stock Shows Positive Momentum with 2.47% Rise on March 7, 2024
On March 7, 2024, GENI stock showed positive price momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well relative to its historical price levels and is in an uptrend.
The price of GENI shares increased by $0.17 since the market last closed, representing a 2.47% rise. The stock opened at $6.73, which was $0.05 higher than its previous close. This opening price suggests that there was strong demand for GENI shares at the beginning of the trading day.
GENI Stock Performance Analysis: Revenue Up, Net Income Down – March 7, 2024
On March 7, 2024, GENI stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $412.98 million for the past year, which represents a 21.1% increase compared to the previous year. However, the total revenue remained flat since the last quarter at $127.17 million. In terms of net income, GENI reported a net loss of $85.53 million for the past year, which is an improvement of 52.91% compared to the previous year. However, the net income decreased by 231.03% since the last quarter to -$38.45 million. Earnings per share (EPS) for GENI stock was reported at -$0.38 for the past year, showing an increase of 58.52% compared to the previous year. However, the EPS decreased by 203.96% since the last quarter to -$0.17. Overall, GENI stock showed a positive trend in terms of total revenue and net income compared to the previous year. However, the company experienced a significant decrease in net income and EPS since the last quarter. Investors may want to closely monitor GENI stock performance and consider the factors contributing to these fluctuations before making any investment decisions.
